Cyrus V DeSouza MD

PubMed

• Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
  Nikolaus Marx, John E Deanfield, Johannes F E Mann, Rosario Arechavaleta, Stephen C Bain
  Circulation. 2025-03-29
• Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators across Demographic Subgroups.
  Ildiko Lingvay, Julie Krogsdahl Bache, Cyrus V Desouza, Mariana Fragão-Marques, Andrea Navarria
  The Journal of Clinical Endocrinology and Metabolism. 2025-03-19
• Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT).
  Michael E McCullough, Lisa R Letourneau-Freiberg, Rochelle N Naylor, Siri Atma W Greeley, David T Broome
  Journal of Diabetes Science and Technology. 2025-01-09

Journal Articles

• Effect of Behavioral Therapy with in-Clinic or Telephone Group Visits vs in-Clinic Individual Visits on Weight Loss Among Patients with Obesity in Rural Clinical Practice  
  Cyrus Desouza, Alexandra R Brown, Leslie Eiland, JAMA
• A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients with Type 2 Diabetes Suboptimally Controlled on Diet and Exe...  
  Ildiko Lingvay, Cyrus V Desouza, Diabetes Care

Lectures

• Achieving Glycaemic Control Without Weight Gain, Hypoglycaemia, or Gastrointestinal Adverse Events in Type 2 Diabetes in the SUSTAIN Clinical Trial Programme 
  Omaha, NE - 6/14/2014